Erasca Inc (ERAS)
Healthcare
Biotechnology
18.20 $
-2.8%
vs. previous close
Closing price · As of: 31. Jul 2026
Erasca Inc (ERAS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -95 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -10 | -33 | -80 | -103 | -101 | -109 | -95 | |
| 0.3 | 0.5 | 0.8 | 2.6 | 3.7 | 3.8 | 3.1 | |
| 0.1 | 0.8 | 8.3 | 20 | 26 | 27 | 25 | |
| -0.4 | 65 | 19 | 122 | – | – | – | |
| 1.7 | 3.3 | 7.7 | 16 | 0.8 | 1.7 | -3.3 | |
| 0.6 | 39 | 19 | 17 | 1.8 | 23 | 0.1 | |
| -21 | -71 | -65 | -71 | -91 | -157 | 100 | |
| – | – | 1.1 | 0.8 | 0.8 | 0.8 | 0.7 | |
| 17 | 140 | 439 | 98 | 1.3 | 241 | 1.1 | |
| -14 | 36 | 295 | -76 | -191 | -25 | 6.1 | |
| -11 | -71 | -98 | -120 | -103 | -132 | -96 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.